Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -24.04%22.55M | 25.48%27.78M | -13.97%23.69M | 16.37%103.74M | -6.83%24.38M | 57.85%29.68M | 11.31%22.14M | 13.39%27.53M | 46.05%89.15M | 7.25%26.17M |
| Operating revenue | -24.04%22.55M | 25.48%27.78M | -13.97%23.69M | 16.37%103.74M | -6.83%24.38M | 57.85%29.68M | 11.31%22.14M | 13.39%27.53M | 46.05%89.15M | 7.25%26.17M |
| Cost of revenue | 17.15%27.81M | 27.24%31.51M | 5.82%25.6M | -0.80%100.59M | 3.00%27.9M | -7.15%23.74M | 8.92%24.76M | -5.28%24.19M | 66.47%101.41M | 8.69%27.09M |
| Gross profit | -188.41%-5.26M | -42.00%-3.73M | -157.41%-1.92M | 125.67%3.15M | -284.57%-3.52M | 187.99%5.95M | 7.80%-2.62M | 365.00%3.34M | -10,066.67%-12.26M | -76.45%-914K |
| Operating expense | -34.67%3.63M | -12.99%3.97M | -26.20%3.57M | 18.89%19.62M | 21.13%4.67M | 13.59%5.56M | 26.48%4.56M | 4.31%4.84M | -1.21%16.5M | -36.42%3.86M |
| Selling and administrative expenses | 12.80%2.09M | 0.73%1.94M | -4.78%1.81M | 19.31%7.78M | 36.90%2.1M | 6.87%1.85M | 30.95%1.93M | -9.98%1.9M | -21.75%6.52M | -63.09%1.53M |
| -General and administrative expense | 12.80%2.09M | 0.73%1.94M | -4.78%1.81M | 19.31%7.78M | 36.90%2.1M | 6.87%1.85M | 30.95%1.93M | -9.98%1.9M | -21.75%6.52M | -63.09%1.53M |
| Other operating expenses | -58.38%1.54M | -23.02%2.03M | -40.11%1.76M | 18.62%11.84M | 10.72%2.57M | 17.27%3.71M | 23.39%2.63M | 16.30%2.93M | 19.23%9.98M | 21.62%2.32M |
| Operating profit | -2,385.09%-8.89M | -7.10%-7.69M | -266.64%-5.49M | 42.72%-16.48M | -71.60%-8.19M | 103.34%389K | -11.35%-7.18M | 74.62%-1.5M | -73.45%-28.76M | 27.54%-4.77M |
| Net non-operating interest income (expenses) | -11.49%-1.95M | -1.50%-1.82M | 7.96%-1.76M | 44.74%-5.08M | 112.09%374K | -22.89%-1.75M | 15.00%-1.8M | 25.65%-1.91M | -136.54%-9.2M | -237.40%-3.09M |
| Non-operating interest expense | 11.49%1.95M | 1.50%1.82M | -7.96%1.76M | -44.74%5.08M | -112.09%-374K | 22.89%1.75M | -15.00%1.8M | -25.65%1.91M | 124.53%9.2M | 217.33%3.09M |
| Other net income (expenses) | -309.12%-20.09M | 11.43%-2.28M | 58.09%-5.5M | -1,758.96%-44.39M | -1,322.25%-23.78M | -260.67%-4.91M | -130.14%-2.57M | -395.43%-13.13M | -459.25%-2.39M | 30.01%-1.67M |
| Gain on sale of security | -844.00%-12.66M | -128.16%-1.59M | 202.52%2.4M | -15.05%1.14M | 3,730.92%5.52M | -151.22%-1.34M | -92.80%-696K | -208.70%-2.34M | 101.80%1.34M | 93.14%-152K |
| Special income (charges) | --0 | --0 | --0 | -11,058.81%-35.49M | -8,452.20%-27.2M | --0 | --0 | ---8.29M | 83.30%-318K | -1,282.61%-318K |
| -Less:Restructuring and mergern&acquisition | --0 | --0 | --0 | --8.29M | --0 | --0 | --0 | --8.29M | --0 | --0 |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --27.2M | ---- | ---- | ---- | ---- | --0 | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --318K | ---- |
| Other non-operating income (expenses) | -108.15%-7.43M | 63.19%-691K | -216.54%-7.9M | -194.46%-10.05M | -74.96%-2.1M | -914.84%-3.57M | -147.95%-1.88M | -32.05%-2.5M | -520.20%-3.41M | -701.33%-1.2M |
| Income before tax | -393.19%-30.93M | -2.10%-11.79M | 22.92%-12.75M | -63.44%-65.95M | -231.27%-31.59M | 37.42%-6.27M | -19.32%-11.55M | -48.78%-16.54M | -93.07%-40.35M | 3.57%-9.54M |
| Income tax | -123.71%-161K | 72.06%-88K | -19.10%610K | 163.43%869K | -162.59%-251K | 385.29%679K | 84.73%-315K | 42.80%754K | -180.40%-1.37M | -64.70%401K |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -342.69%-30.77M | -4.18%-11.71M | 22.75%-13.36M | -71.42%-66.82M | -215.38%-31.34M | 28.95%-6.95M | -47.50%-11.24M | -48.51%-17.29M | -72.45%-38.98M | 9.87%-9.94M |
| Net income continuous operations | -342.69%-30.77M | -4.18%-11.71M | 22.75%-13.36M | -71.42%-66.82M | -215.38%-31.34M | 28.95%-6.95M | -47.50%-11.24M | -48.51%-17.29M | -72.45%-38.98M | 9.87%-9.94M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -342.69%-30.77M | -4.18%-11.71M | 22.75%-13.36M | -71.42%-66.82M | -215.38%-31.34M | 28.95%-6.95M | -47.50%-11.24M | -48.51%-17.29M | -72.45%-38.98M | 9.87%-9.94M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -342.69%-30.77M | -4.18%-11.71M | 22.75%-13.36M | -71.42%-66.82M | -215.38%-31.34M | 28.95%-6.95M | -47.50%-11.24M | -48.51%-17.29M | -72.45%-38.98M | 9.87%-9.94M |
| Diluted earnings per share | -266.67%-0.11 | 20.00%-0.04 | 25.00%-0.06 | -30.43%-0.3 | -180.00%-0.14 | 50.00%-0.03 | 0.00%-0.05 | 0.00%-0.08 | -43.75%-0.23 | 37.50%-0.05 |
| Basic earnings per share | -266.67%-0.11 | 20.00%-0.04 | 25.00%-0.06 | -30.43%-0.3 | -180.00%-0.14 | 50.00%-0.03 | 0.00%-0.05 | 0.00%-0.08 | -43.75%-0.23 | 37.50%-0.05 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.